This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2bxq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2bxq.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2bxq.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2bxq| PDB=2bxq | SCENE= }}
{{STRUCTURE_2bxq| PDB=2bxq | SCENE= }}
-
'''HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN'''
+
===HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN===
-
==Overview==
+
<!--
-
Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concentrations. The problem of overcoming the binding affinity of lead compounds for HSA represents a major challenge in drug development. Crystallographic analysis of 17 different complexes of HSA with a wide variety of drugs and small-molecule toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation. Numerous secondary binding sites for drugs distributed across the protein have also been identified. The binding of fatty acids, the primary physiological ligand for the protein, is shown to alter the polarity and increase the volume of drug site 1. These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16169013}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16169013 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16169013}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Drug-binding,myristate,phenylbutazone,indomethacin]]
[[Category: Drug-binding,myristate,phenylbutazone,indomethacin]]
[[Category: Transport protein]]
[[Category: Transport protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 20:56:34 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 21:55:38 2008''

Revision as of 18:55, 27 July 2008

Image:2bxq.png

Template:STRUCTURE 2bxq

HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN

Template:ABSTRACT PUBMED 16169013

About this Structure

2BXQ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural basis of the drug-binding specificity of human serum albumin., Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S, J Mol Biol. 2005 Oct 14;353(1):38-52. PMID:16169013

Page seeded by OCA on Sun Jul 27 21:55:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2bxq"
Personal tools